While we depend on the FDA to keep us safe from unsavory medical manufacturing and drug processing practices that are rampant in other parts of the world, there are many within the diabetes community who feel the FDA is too slow to approve new diabetes products, especially when compared with its European counterpart, the European Medicines Agency (EMA).

Read more